Both in Medical Labs
GRAIL vs Guardant Health
Over the past year GRAL returned +56.4% and GH returned +72.2%; their daily moves had a correlation of 0.44.
GRAL +56.4% GH +72.2%Growth of $1, one year, split-adjusted
| Metric | GRAL | GH |
|---|---|---|
| Price | $140.51 | $170.37 |
| Market cap | $6.28B | $22.86B |
| Today | +0.76% | −2.65% |
| 1 month | +2.3% | −0.2% |
| 6 months | +123.9% | +84.7% |
| Year to date | +64.2% | +66.8% |
| 1 year | — | +72.2% |
| Revenue growth (YoY) | +25.7% | +44.3% |
| Gross margin | −28.1% | 65.4% |
| Net margin | −246.7% | −35.9% |
| P/E (TTM) | — | — |
| Price / sales | 38.0× | 19.3× |
| Net cash | $861.6M | -$449.5M |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 44.7% |
| Short % of float | 19.3% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).